Here is information on the latest US FDA approvals, the week of December 9 - December 15, 2023Belzutifan (Welireg) for RCCThe FDA has approved belzutifan (Welireg) for patients with advanced…
Here is information on the latest US FDA approvals, the week of December 2 - December 8, 2023 Iptacopan (Fabhalta) for PNH The FDA has approved iptacopan (Fabhalta) as the first…
Here is information on the latest US FDA approvals, the week of November 20 - December 1, 2023Nirogacestat (Ogsiveo) For Desmoid TumorsThe FDA has approved nirogacestat (Ogsiveo) tablets for adult…
Here is information on the latest US FDA approvals, the week of November 13 - November 17, 2023 Capivasertib (Truqap) for Breast CancerThe FDA has approved capivasertib (Truqap) in combination…
Here is information on the latest US FDA approvals, the week of November 6 - November 10, 2023Tirzepatide (Zepbound) for Adults With ObesityThe FDA has approved Zepbound (tirzepatide) injection for…
Pembrolizumab (Keytruda) for Metastatic Biliary Tract CancerThe FDA has granted approval for pembrolizumab (Keytruda) in combination with gemcitabine and cisplatin for the treatment of patients diagnosed with locally advanced unresectable…
Here is information on the latest US FDA approvals, the week of October 23 - October 27, 2023 Loqtorzi (toripalimab-tpzi) for Nasopharyngeal Carcinoma The FDA has approved Loqtorzi (toripalimab-tpzi), a…
Here is information on the latest US FDA approvals, the week of October 16 - October 20, 2023 Bimzelx (bimekizumab) for Moderate-to-Severe Plaque Psoriasis The FDA has approved BIMZELX® (bimekizumab-bkzx)…
Here is information on the latest US FDA approvals, the week of October 9 – October 13, 2023Velsipity (Etrasimod) for UCThe FDA has approved Velsipity (etrasimod) for treating moderate to…
Here is information on the latest US FDA approvals, the week of October 2 – October 6, 2023 Novavax COVID VaccineThe updated COVID-19 vaccine made by Novavax is now approved for…